Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Quantitative immunophenotypic characterization, cryopreservation, and enrichment of second- and third-trimester human fetal cord blood hematopoietic stem cells (progenitor cells).

Surbek DV, Holzgreve W, Jansen W, Heim D, Garritsen H, Nissen C, Wodnar-Filipowicz A.

Am J Obstet Gynecol. 1998 Nov;179(5):1228-33.

PMID:
9822506
2.

The activity in ex vivo expansion of cord blood myeloid progenitor cells before and after cryopreservation.

Wang SY, Hsu ML, Huang MZ, Hsu HC, Tzeng CH, Hung JH, Ho CK.

Acta Haematol. 2001;105(1):38-44.

PMID:
11340252
3.
4.

Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation.

Pahal GS, Jauniaux E, Kinnon C, Thrasher AJ, Rodeck CH.

Am J Obstet Gynecol. 2000 Oct;183(4):1029-34.

PMID:
11035358
5.
6.

Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells.

McCowage GB, Phillips KL, Gentry TL, Hull S, Kurtzberg J, Gilboa E, Smith C.

Exp Hematol. 1998 Apr;26(4):288-98.

PMID:
9546311
7.

Loss of CD38 antigen on CD34+CD38+ cells during short-term culture.

von Laer D, Corovic A, Vogt B, Fehse B, Roscher S, Rimek A, Baum C, Ostertag W.

Leukemia. 2000 May;14(5):947-8. No abstract available.

PMID:
10803533
10.

Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells.

Verstegen MM, van Hennik PB, Terpstra W, van den Bos C, Wielenga JJ, van Rooijen N, Ploemacher RE, Wagemaker G, Wognum AW.

Blood. 1998 Mar 15;91(6):1966-76.

11.
12.

Glass needle-mediated microinjection of macromolecules and transgenes into primary human blood stem/progenitor cells.

Davis BR, Yannariello-Brown J, Prokopishyn NL, Luo Z, Smith MR, Wang J, Carsrud ND, Brown DB.

Blood. 2000 Jan 15;95(2):437-44.

13.

Identification of novel circulating human embryonic blood stem cells.

Gallacher L, Murdoch B, Wu D, Karanu F, Fellows F, Bhatia M.

Blood. 2000 Sep 1;96(5):1740-7.

14.

[Growth properties of hematopoietic stem/progenitor cells in the second or third trimester and term fetal cord blood].

Ma Y, Zou P, Xiao J, Huang S.

Zhonghua Yi Xue Za Zhi. 2002 Mar;82(5):330-3. Chinese.

PMID:
11953192
16.

Stem cell enumeration in cord blood vs bone marrow and peripheral blood.

Bertolini F, Battaglia M, Lanza A, Gibelli N, Palermo B, Pavesi L, Robustelli della Cuna G.

Bone Marrow Transplant. 1998 Jul;22 Suppl 1:S57.

PMID:
9715890
17.

A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.

Astori G, Malangone W, Adami V, Risso A, Dorotea L, Falasca E, Marini L, Spizzo R, Bigi L, Sala P, Tonutti E, Biffoni F, Rinaldi C, Del Frate G, Pittino M, Degrassi A.

Blood Cells Mol Dis. 2001 Jul-Aug;27(4):715-24; discussion 725-7.

PMID:
11778655
18.

High-efficiency retroviral transduction of fetal liver CD38-CD34++ cells: implications for in utero and ex utero gene therapy.

Ohkubo T, Bárcena A, Smith CA, Harrison MR, Muench MO.

Fetal Diagn Ther. 2001 Sep-Oct;16(5):299-307.

PMID:
11509853
19.

Supplemental Content

Support Center